Coya Therapeutics Ratios (2021-2026) | COYA

Ratios Dec2021 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Profitability
EBT Margin (Quarter) -63.48%-3,982.96%-84.42%-625,479.97%-2,833.35%-3,725.17%-136.40%-216.36%-2,869.63%
EBIT Margin (Quarter) 30.24%-4,322.84%-94.48%-209,031.51%-2,976.89%-3,920.47%-68.26%-152.30%-3,042.13%
EBITDA Margin (Quarter) 30.24%-4,322.84%-94.48%-209,031.51%-2,976.89%-3,920.47%-68.26%-152.30%-3,042.13%
Operating Margin (Quarter) 30.24%-4,322.84%-94.48%-209,031.51%-2,976.89%-3,920.47%-68.26%-152.30%-3,042.13%
Net Margin (Quarter) -63.48%-3,982.96%-84.42%-625,479.97%-2,833.35%-3,725.17%-136.40%-216.36%-2,869.63%
FCF Margin (Quarter) -37.34%1,691.82%-133.23%-123,451.18%-1,096.72%-3,528.56%-31.72%-25.43%-2,472.07%
Efficiency
Assets Average (Quarter) 12.91M15.94M13.18M26.58M39.33M38.67M37.75M39.95M41.38M35.93M32.75M41.00M51.61M
Asset Utilization Ratio (Quarter) 0.230.160.250.250.090.090.010.120.190.15
Leverage & Solvency
Interest Coverage Ratio (Quarter) -2.00-2.68-2.75-3.690.32-0.56-0.99-1.14-0.50-1.84-2.50-1.00-2.38-12.64
Times Interest Earned (Quarter) -2.00-2.68-2.75-3.690.32-0.56-0.99-1.14-0.50-1.84-2.50-1.00-2.38-12.64
Valuation
Enterprise Value (Quarter) -4.34M-5.93M-16.32M-13.10M-10.89M-32.63M-35.99M-36.60M-31.06M-38.34M-35.53M-29.76M-28.13M-46.82M-50.72M
Return Ratios
Return on Sales (Quarter) -0.01%-0.40%-0.01%-0.02%-62.55%-0.28%-0.37%-0.01%-0.02%-0.29%
Return on Capital Employed (Quarter) -94.60%-73.49%-103.04%-36.71%-29.95%-30.05%-32.05%-47.75%-52.50%-71.98%-70.85%-64.21%-46.85%
Return on Assets (Quarter) -0.01%-0.01%-0.01%-0.01%0.00%0.00%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%